Cargando…
New Aspects on the Treatment of Retinopathy of Prematurity: Currently Available Therapies and Emerging Novel Therapeutics
Retinopathy of prematurity (ROP) is a rare proliferative ocular disorder in preterm infants. Because of the advancements in neonatal care, the incidence of ROP has increased gradually. Now, ROP is one of the leading causes of blindness in children. Preterm infants with immature retinal development a...
Autor principal: | Ryu, Juhee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369302/ https://www.ncbi.nlm.nih.gov/pubmed/35955664 http://dx.doi.org/10.3390/ijms23158529 |
Ejemplares similares
-
Noncoding RNAs as a novel approach to target retinopathy of prematurity
por: Kim, Hyunjong, et al.
Publicado: (2022) -
Current screening and treatments in retinopathy of prematurity in the US
por: Suelves, Ana M, et al.
Publicado: (2016) -
Concurrent Physiological and Pathological Angiogenesis in Retinopathy of Prematurity and Emerging Therapies
por: Dai, Chang, et al.
Publicado: (2021) -
Retinopathy of prematurity: inflammation, choroidal degeneration, and novel promising therapeutic strategies
por: Rivera, José Carlos, et al.
Publicado: (2017) -
Retinopathy of prematurity: a review of epidemiology and current treatment strategies
por: Hong, Eun Hee, et al.
Publicado: (2021)